SCHEMBL9584643

SCHEMBL9584643

[CH2]CCCCC(Br)CCCCCCCC

nearest known ligand 0.43

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
LCK P06239 1/20 0.43
PPARD Q03181 1/20 0.43
ZDHHC20 Q5W0Z9 1/20 0.43
ZDHHC2 Q9UIJ5 1/20 0.43
ZDHHC7 Q9NXF8 1/20 0.39
LMNA P02545 1/20 0.39
DNM1 Q05193 2/20 0.39
TSHR P16473 1/20 0.38
THRB P10828 1/20 0.38
FAAH O00519 1/20 0.38
OPRM1 P35372 1/20 0.37
GPR84 Q9NQS5 3/20 0.35
FDPS P14324 3/20 0.35
SPHK1 Q9NYA1 1/20 0.35
FFAR1 O14842 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28355783 0.95 LCK (0.43) LCKPPARDZDHHC20ZDHHC2ZDHHC7
SCHEMBL10600385 0.95 LCK (0.39) LCKPPARDZDHHC20ZDHHC2ZDHHC7
SCHEMBL14777223 0.92 LCK (0.38) LCKPPARDZDHHC20ZDHHC2ZDHHC7
SCHEMBL611888 0.91 LCK (0.43) LCKPPARDZDHHC20ZDHHC2ZDHHC7
SCHEMBL7647649 0.91 LCK (0.43) LCKPPARDZDHHC20ZDHHC2ZDHHC7
SCHEMBL9951189 0.91 LCK (0.43) LCKPPARDZDHHC20ZDHHC2ZDHHC7
SCHEMBL9584564 0.91 LCK (0.43) LCKPPARDZDHHC20ZDHHC2ZDHHC7
SCHEMBL15255049 0.88 LCK (0.36) LCKPPARDZDHHC20ZDHHC2ZDHHC7
SCHEMBL9432813 0.88 LCK (0.31) LCKPPARDZDHHC20ZDHHC2
SCHEMBL12214087 0.87 LCK (0.52) LCKPPARDZDHHC20ZDHHC2ZDHHC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5204346-A Cognition activators; analgesics; antidepressants; vasodilation; cardiovascular and urogential disorders; FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1993-04-20 US disclosed
EP-0467248-A2 Pyrazolopyridine compound and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1992-01-22 EP disclosed